SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001399529-21-000063
Filing Date
2021-04-05
Accepted
2021-04-05 21:39:09
Documents
1
Period of Report
2021-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_161767306148516.html 4/A  
1 FORM 4/A wf-form4a_161767306148516.xml 4/A 6076
  Complete submission text file 0001399529-21-000063.txt   7477
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
Brown Bob D (Reporting) CIK: 0001598479 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36281 | Film No.: 21807959